{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:20:55Z","timestamp":1773879655188,"version":"3.50.1"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1004610","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T19:27:04Z","timestamp":1420745224000},"page":"e1004610","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protective Efficacy of Centralized and Polyvalent Envelope Immunogens in an Attenuated Equine Lentivirus Vaccine"],"prefix":"10.1371","volume":"11","author":[{"given":"Jodi K.","family":"Craigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corin","family":"Ezzelarab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Horohov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.","family":"Issel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Montelaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"B Gaschen","year":"2002","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/157016206777709456","article-title":"Global genetic variation of HIV-1 infection","volume":"4","author":"CG Anastassopoulou","year":"2006","journal-title":"Curr HIV Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.coi.2006.05.012","article-title":"The challenges of host and viral diversity in HIV vaccine design","volume":"18","author":"C Brander","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"ref4","first-page":"19","article-title":"Evolutionary and immunological implications of contemporary HIV-1 variation","volume":"58","author":"B Korber","year":"2001","journal-title":"BrMedBull"},{"key":"ref5","first-page":"171","article-title":"Evolutionary dynamics of HIV-1 and the control of AIDS","volume":"299","author":"JI Mullins","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/JVI.02297-12","article-title":"Antigenicity and immunogenicity of transmitted\/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1","volume":"87","author":"HX Liao","year":"2013","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1586\/14760584.3.4.S151","article-title":"Immunogen sequence: the fourth tier of AIDS vaccine design","volume":"3","author":"JI Mullins","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.299.5612.1515c","article-title":"Consensus and ancestral state HIV vaccines","volume":"299","author":"DC Nickle","year":"2003","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/JVI.79.2.1154-1163.2005","article-title":"Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein","volume":"79","author":"F Gao","year":"2005","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"11214","DOI":"10.1128\/JVI.79.17.11214-11224.2005","article-title":"Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope","volume":"79","author":"NA Doria-Rose","year":"2005","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2006.10.017","article-title":"Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins","volume":"360","author":"DL Kothe","year":"2007","journal-title":"Virology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.virol.2006.05.011","article-title":"Ancestral and consensus envelope immunogens for HIV-1 subtype C","volume":"352","author":"DL Kothe","year":"2006","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2012.03.012","article-title":"Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens","volume":"428","author":"S Santra","year":"2012","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1073\/pnas.0803352105","article-title":"A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys","volume":"105","author":"S Santra","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.virol.2006.04.043","article-title":"A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses","volume":"353","author":"HX Liao","year":"2006","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/157016207782418498","article-title":"Centralized HIV-1 envelope immunogens and neutralizing antibodies","volume":"5","author":"F Gao","year":"2007","journal-title":"Curr HIV Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1128\/JVI.02484-05","article-title":"Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen","volume":"80","author":"EA Weaver","year":"2006","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-10-102","article-title":"Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge","volume":"10","author":"HS Eugene","year":"2013","journal-title":"Virol J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/j.vaccine.2009.04.032","article-title":"Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines","volume":"27","author":"SP Mcburney","year":"2009","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Montelaro RC, Ball JM, Rushlow K (1993) Equine retroviruses. In: Levy JA, editor. The Retroviridae. New York, N.Y.: Plenum Press. pp. 257\u2013360.","DOI":"10.1007\/978-1-4899-1627-3_5"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/JVI.74.7.3112-3121.2000","article-title":"Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids","volume":"74","author":"SM Harrold","year":"2000","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1128\/JVI.74.13.5968-5981.2000","article-title":"Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus","volume":"74","author":"SA Hammond","year":"2000","journal-title":"J Virol"},{"key":"ref23","first-page":"8","article-title":"Recrudesence of equine infectious anemia by treatment with immunosuppressive drugs","volume":"16","author":"Y Kono","year":"1976","journal-title":"Nat Inst Anim Hlth Quart"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.3390\/v5122963","article-title":"Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity","volume":"5","author":"JK Craigo","year":"2013","journal-title":"Viruses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/fvl.10.85","article-title":"Equine Infectious Anemia Virus Infection and Immunity: Lessons for Aids Vaccine Development","volume":"6","author":"JK Craigo","year":"2011","journal-title":"Future Virol"},{"key":"ref26","unstructured":"Craigo JK, Montelaro RC (2008) Equine Infectious Anemia Virus (Retroviridae). Encyclopedia of Virology. Third ed. Oxford: Elsevier. pp. 167\u2013174."},{"key":"ref27","unstructured":"Craigo JK, Montelaro RC (2010) Lentivirus Tropism and Disease. In: Desport M, editor. Lentiviruses and Macrophages: Molecular and Cellular Interactions: Horizon Academic Press. pp. 1\u201323."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e66093","DOI":"10.1371\/journal.pone.0066093","article-title":"Envelope determinants of equine lentiviral vaccine protection","volume":"8","author":"JK Craigo","year":"2013","journal-title":"PLoS ONE"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157016210790416398","article-title":"EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy","volume":"8","author":"JK Craigo","year":"2010","journal-title":"Curr HIV Res"},{"key":"ref30","first-page":"S255","article-title":"Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development","volume":"14","author":"RC Montelaro","year":"1998","journal-title":"AIDS ResHumRetroviruses"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.vaccine.2006.09.040","article-title":"Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines","volume":"25","author":"JK Craigo","year":"2007","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/JVI.79.5.2666-2677.2005","article-title":"Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy","volume":"79","author":"JK Craigo","year":"2005","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1128\/JVI.77.13.7244-7253.2003","article-title":"A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses","volume":"77","author":"F Li","year":"2003","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"15105","DOI":"10.1073\/pnas.0706449104","article-title":"Envelope variation as a primary determinant of lentiviral vaccine efficacy","volume":"104","author":"JK Craigo","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","first-page":"S111","article-title":"AIDS 1995. Vaccines and immunology: overview","volume":"9","author":"RC Montelaro","year":"1995","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1089\/088922200750005976","article-title":"Live Attenuated HIV Vaccines: A Proposal for Further Research and Development","volume":"16","author":"J Mills","year":"2000","journal-title":"AIDS ResHumRetroviruses"},{"key":"ref37","first-page":"113","article-title":"FIV vaccine development and its importance to veterinary and human medicine: a review. FIV vaccine 2002 update and review","volume":"90","author":"EW Uhl","year":"2002","journal-title":"VetImmunolImmunopathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni1296","article-title":"HIV vaccine design: insights from live attenuated SIV vaccines","volume":"7","author":"WC Koff","year":"2006","journal-title":"Nat Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.1016\/j.vaccine.2010.10.003","article-title":"Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease","volume":"28","author":"JK Craigo","year":"2010","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/JVI.02028-07","article-title":"Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition","volume":"82","author":"TL Tagmyer","year":"2008","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1099\/vir.0.82391-0","article-title":"Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus","volume":"88","author":"TL Tagmyer","year":"2007","journal-title":"J Gen Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1128\/JVI.75.10.4570-4583.2001","article-title":"Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies","volume":"75","author":"C Leroux","year":"2001","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1128\/JVI.71.12.9627-9639.1997","article-title":"Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony","volume":"71","author":"C Leroux","year":"1997","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.virol.2005.09.006","article-title":"Apparent elimination of EIAV ancestral species in a long-term inapparent carrier","volume":"344","author":"JK Craigo","year":"2006","journal-title":"Virology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0042-6822(03)00351-9","article-title":"Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides","volume":"313","author":"RF Cook","year":"2003","journal-title":"Virology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jviromet.2012.07.007","article-title":"Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus","volume":"185","author":"JK Craigo","year":"2012","journal-title":"J Virol Methods"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1128\/JVI.76.21.10588-10597.2002","article-title":"Equine Infectious Anemia Virus Envelope Evolution In Vivo during Persistent Infection Progressively Increases Resistance to In Vitro Serum Antibody Neutralization as a Dominant Phenotype","volume":"76","author":"L Howe","year":"2002","journal-title":"The Journal of Virology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1128\/JVI.72.10.8344-8348.1998","article-title":"The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro","volume":"72","author":"F Li","year":"1998","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/JVI.70.6.3346-3354.1996","article-title":"Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus","volume":"70","author":"DL Lichtenstein","year":"1996","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/JVI.66.6.3398-3408.1992","article-title":"Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus","volume":"66","author":"CJ Issel","year":"1992","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/JVI.71.5.3840-3852.1997","article-title":"Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process","volume":"71","author":"SA Hammond","year":"1997","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/aid.2009.0258","article-title":"Similar T-cell immune responses induced by group M consensus env immunogens with wild-type or minimum consensus variable regions","volume":"26","author":"EA Weaver","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/CVI.05533-11","article-title":"Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines","volume":"19","author":"BM Giles","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jis232","article-title":"A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection","volume":"205","author":"BM Giles","year":"2012","journal-title":"J Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/erv.12.3","article-title":"Computationally optimized antigens to overcome influenza viral diversity","volume":"11","author":"BM Giles","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"BM Giles","year":"2011","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2006.10.017","article-title":"Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins","volume":"360","author":"DL Kothe","year":"2007","journal-title":"Virology"},{"key":"ref58","unstructured":"Swofford DL (2001) PAUP: Phylogenetic Analysis Using Parsimony and Other Methods. Sunderlan, MA: Sinauer Associates."},{"key":"ref59","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1051\/vetres:2004020","article-title":"Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?","volume":"35","author":"C Leroux","year":"2004","journal-title":"Vet Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0166-0934(02)00101-5","article-title":"Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV)","volume":"105","author":"RF Cook","year":"2002","journal-title":"J Virol Methods"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vetimm.2012.06.018","article-title":"The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies","volume":"148","author":"C Liu","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data","volume":"339","author":"C Ramakers","year":"2003","journal-title":"Neurosci Lett"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1004610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T20:13:15Z","timestamp":1598645595000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1004610"}},"subtitle":[],"editor":[{"given":"Ronald","family":"Swanstrom","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1004610","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]}}}